|Bid||15.52 x 1100|
|Ask||15.52 x 1800|
|Day's Range||15.38 - 16.41|
|52 Week Range||0.97 - 21.50|
|Beta (5Y Monthly)||1.86|
|PE Ratio (TTM)||31.28|
|Earnings Date||Nov 18, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Retractable Technologies Inc. said in a securities filing on Feb. 16 that it was awarded a $54.2 million contract from the federal government. to supply low dead space safety syringes. These types of syringes are used to extract an extra dose from the vials of BioNTech SE and Pfizer Inc.'s COVID-19 vaccine. The contract amount includes payment for the products and transporting them over a five-month period. It also includes options that could increase the value of the contract to $92.7 million. Retractable's stock has rallied 987.4% over the past 12 months. The broader S&P 500 is up 16.3%.
Most readers would already be aware that Retractable Technologies' (NYSEMKT:RVP) stock increased significantly by 172...
Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $10,041 and $39,050, respectively. Over the entire accrual period, the dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from October 1, 2020 through date of conversion or December 31, 2020 whichever is applicable. The dividends will be paid on January 29, 2021. All Series I Class B Convertible Preferred Stock was redeemed as of December 31, 2020. The record date for the Series II Class B Convertible Stockholders is January 19, 2021.